SCHEMBL4286115

SCHEMBL4286115

COc1ccc(Nc2ccn[nH]2)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 1/20 0.54
▸ AURKB Q96GD4 1/20 0.54
▸ EGFR P00533 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ CLK4 Q9HAZ1 1/20 0.47
▸ MAPT P10636 5/20 0.47
▸ CHEK1 O14757 1/20 0.46
▸ PIM1 P11309 1/20 0.45
▸ ABCG2 Q9UNQ0 3/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ CLK1 P49759 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4432542 0.83 KDR (0.49) KDRAURKBEGFRALDH1A1USP2
SCHEMBL4430780 0.78 MAPT (0.55) KDRAURKBALDH1A1MAPK1MAPT
SCHEMBL30358959 0.74 MAPT (0.61) ALDH1A1TP53MAPTKMT2AMEN1
SCHEMBL7369051 0.73 KMT2A (0.54) EGFRALDH1A1CYP1A2CYP2C19MAPT
SCHEMBL13725360 0.72 AURKA (0.52) KDREGFRMAPTCHEK1PIM1
SCHEMBL3269159 0.72 ABCG2 (0.67) EGFRCYP1A2CYP2C19MAPTPIM1
SCHEMBL1491116 0.72 HAO1 (0.46) KDRAURKBCYP3A4MAPTSMN1; SMN2
SCHEMBL21345464 0.70 ALOX5 (0.58) KDREGFRALDH1A1TP53MAPT
SCHEMBL14906047 0.69 GRM4 (0.72) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL2583806 0.69 MAPT (0.50) ALDH1A1TP53CYP1A2CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081933-A1 PYRAZOLOPYRIMIDINES AS P13K LIPID KINASE INHIBITORS Novartis Ag (CH) 2009-07-29 — — EP disclosed
WO-2008037477-A1 PYRAZOLOPYRIMIDINES AS P13K LIPID KINASE INHIBITORS NOVARTIS AG (CH) 2008-04-03 — — WO disclosed
Send feedback